We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Renal Cell Carcinoma

Journal Scan / Research · September 01, 2020

Platelet-to-Lymphocyte Ratio Predicts Survival Outcomes in Patients With Synchronous mRCC

Investigative and Clinical Urology


Additional Info

Investigative and Clinical Urology
The Platelet-to-Lymphocyte Ratio as a Significant Prognostic Factor to Predict Survival Outcomes in Patients With Synchronous Metastatic Renal Cell Carcinoma
Investig Clin Urol 2020 Jul 23;[EPub Ahead of Print], HD Yuk, M Kang, EC Hwang, JY Park, CW Jeong, C Song, SI Seo, SS Byun, C Kwak, SH Hong, J Chung, H Lee

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading